世界のグルカゴン様ペプチド-1受容体アゴニスト市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glucagon-like Peptide-1 Receptor Agonist Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4261
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、グルカゴン様ペプチド-1受容体アゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・グルカゴン様ペプチド-1受容体アゴニストの市場動向
・企業の競争状況、市場シェア
・グルカゴン様ペプチド-1受容体アゴニストの種類別市場規模と予測2016-2027（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）
・グルカゴン様ペプチド-1受容体アゴニストの用途別市場規模と予測2016-2027（固形腫瘍、血液関連腫瘍）
・グルカゴン様ペプチド-1受容体アゴニストの北米市場規模2016-2027（アメリカ、カナダ）
・グルカゴン様ペプチド-1受容体アゴニストの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・グルカゴン様ペプチド-1受容体アゴニストのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・グルカゴン様ペプチド-1受容体アゴニストの中南米市場規模2016-2027（メキシコ、ブラジル）
・グルカゴン様ペプチド-1受容体アゴニストの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GSK、Novo Nordisk、Lily、Haosoh、Sanofi、AstraZeneca）
・結論

Market Analysis and Insights: Global Glucagon-like Peptide-1 Receptor Agonist Market
The global Glucagon-like Peptide-1 Receptor Agonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glucagon-like Peptide-1 Receptor Agonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glucagon-like Peptide-1 Receptor Agonist market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glucagon-like Peptide-1 Receptor Agonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glucagon-like Peptide-1 Receptor Agonist market.

Global Glucagon-like Peptide-1 Receptor Agonist Scope and Market Size
Glucagon-like Peptide-1 Receptor Agonist market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon-like Peptide-1 Receptor Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Exenatide
Liraglutide
Lixisenatide
Albiglutide
Others

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Novo Nordisk
Lily
Haosoh
Sanofi
AstraZeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exenatide
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Perspective (2016-2027)
2.2 Glucagon-like Peptide-1 Receptor Agonist Growth Trends by Regions
2.2.1 Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glucagon-like Peptide-1 Receptor Agonist Historic Market Share by Regions (2016-2021)
2.2.3 Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Regions (2022-2027)
2.3 Glucagon-like Peptide-1 Receptor Agonist Industry Dynamic
2.3.1 Glucagon-like Peptide-1 Receptor Agonist Market Trends
2.3.2 Glucagon-like Peptide-1 Receptor Agonist Market Drivers
2.3.3 Glucagon-like Peptide-1 Receptor Agonist Market Challenges
2.3.4 Glucagon-like Peptide-1 Receptor Agonist Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Revenue
3.1.1 Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Revenue (2016-2021)
3.1.2 Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Players (2016-2021)
3.2 Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glucagon-like Peptide-1 Receptor Agonist Revenue
3.4 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio
3.4.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2020
3.5 Glucagon-like Peptide-1 Receptor Agonist Key Players Head office and Area Served
3.6 Key Players Glucagon-like Peptide-1 Receptor Agonist Product Solution and Service
3.7 Date of Enter into Glucagon-like Peptide-1 Receptor Agonist Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Type
4.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Type (2016-2021)
4.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2022-2027)

5 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Application
5.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Application (2016-2021)
5.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027)
6.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type
6.2.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021)
6.2.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027)
6.2.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027)
6.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application
6.3.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021)
6.3.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027)
6.3.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027)
6.4 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country
6.4.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021)
6.4.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027)
7.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type
7.2.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021)
7.2.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027)
7.2.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027)
7.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application
7.3.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021)
7.3.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027)
7.3.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027)
7.4 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country
7.4.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021)
7.4.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027)
8.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type
8.2.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027)
8.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application
8.3.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027)
8.4 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region
8.4.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027)
9.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type
9.2.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021)
9.2.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027)
9.2.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027)
9.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application
9.3.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021)
9.3.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027)
9.3.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027)
9.4 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country
9.4.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021)
9.4.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027)
10.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type
10.2.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027)
10.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application
10.3.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027)
10.4 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country
10.4.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Glucagon-like Peptide-1 Receptor Agonist Introduction
11.1.4 GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Introduction
11.2.4 Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Lily
11.3.1 Lily Company Details
11.3.2 Lily Business Overview
11.3.3 Lily Glucagon-like Peptide-1 Receptor Agonist Introduction
11.3.4 Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.3.5 Lily Recent Development
11.4 Haosoh
11.4.1 Haosoh Company Details
11.4.2 Haosoh Business Overview
11.4.3 Haosoh Glucagon-like Peptide-1 Receptor Agonist Introduction
11.4.4 Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.4.5 Haosoh Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Glucagon-like Peptide-1 Receptor Agonist Introduction
11.5.4 Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Introduction
11.6.4 AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
11.6.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exenatide
Table 3. Key Players of Liraglutide
Table 4. Key Players of Lixisenatide
Table 5. Key Players of Albiglutide
Table 6. Key Players of Others
Table 7. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2016-2021)
Table 11. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2022-2027)
Table 13. Glucagon-like Peptide-1 Receptor Agonist Market Trends
Table 14. Glucagon-like Peptide-1 Receptor Agonist Market Drivers
Table 15. Glucagon-like Peptide-1 Receptor Agonist Market Challenges
Table 16. Glucagon-like Peptide-1 Receptor Agonist Market Restraints
Table 17. Global Glucagon-like Peptide-1 Receptor Agonist Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Players (2016-2021)
Table 19. Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2020)
Table 20. Ranking of Global Top Glucagon-like Peptide-1 Receptor Agonist Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Glucagon-like Peptide-1 Receptor Agonist Product Solution and Service
Table 24. Date of Enter into Glucagon-like Peptide-1 Receptor Agonist Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2016-2021)
Table 28. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Application (2016-2021)
Table 32. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Glucagon-like Peptide-1 Receptor Agonist Product
Table 67. GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Product
Table 72. Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Lily Company Details
Table 75. Lily Business Overview
Table 76. Lily Glucagon-like Peptide-1 Receptor Agonist Product
Table 77. Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 78. Lily Recent Development
Table 79. Haosoh Company Details
Table 80. Haosoh Business Overview
Table 81. Haosoh Glucagon-like Peptide-1 Receptor Agonist Product
Table 82. Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 83. Haosoh Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Glucagon-like Peptide-1 Receptor Agonist Product
Table 87. Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Product
Table 92. AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Type: 2020 VS 2027
Figure 2. Exenatide Features
Figure 3. Liraglutide Features
Figure 4. Lixisenatide Features
Figure 5. Albiglutide Features
Figure 6. Others Features
Figure 7. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Application: 2020 VS 2027
Figure 8. Solid Tumors Case Studies
Figure 9. Blood-related Tumors Case Studies
Figure 10. Glucagon-like Peptide-1 Receptor Agonist Report Years Considered
Figure 11. Global Glucagon-like Peptide-1 Receptor Agonist Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Glucagon-like Peptide-1 Receptor Agonist Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions: 2020 VS 2027
Figure 14. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2022-2027)
Figure 15. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Players in 2020
Figure 16. Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2020
Figure 18. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2016-2021)
Figure 19. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2022-2027)
Figure 20. North America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027)
Figure 22. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027)
Figure 23. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027)
Figure 24. United States Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027)
Figure 28. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027)
Figure 29. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027)
Figure 30. Germany Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Region (2016-2027)
Figure 40. China Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027)
Figure 48. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027)
Figure 49. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027)
Figure 50. Mexico Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027)
Figure 56. Turkey Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 61. Lily Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 62. Haosoh Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年）

Global GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
QFJ1-4259 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、GLP-1受容体アゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

グルカゴン様ペプチド2受容体のグローバル市場調査 2019年

Global Glucagon Like Peptide 2 Receptor Market Professional Survey Report 2019
QYR9NV05533 2019年11月12日 109Pages
※本調査レポートは、グルカゴン様ペプチド2受容体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FE-203799、グレパグルチド、GXG-8、HM-1591...

世界のペプチド受容体放射性核種療法（PRRT）市場規模・現状・予測（2021年-2027年）

Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2021-2027
QFJ1-5936 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ペプチド受容体放射性核種療法（PRRT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（胃腸膵臓神経内分泌腫瘍、前腸神経内分泌腫瘍、中腸神経内分泌腫瘍、後腸神経内分泌腫瘍）、用途別市場規模（病院薬局、...

グルカゴン様ペプチド-1（GLP-1）刺激薬のグローバル市場2021

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report 2021
QAF27703 2021年4月2日 135Pages
本市場調査資料では、世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場について種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年...

世界のGLP-1Rアゴニスト市場規模・現状・予測（2021年-2027年）

Global GLP-1R Agonist Market Size, Status and Forecast 2021-2027
QFJ1-4260 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、GLP-1Rアゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模...

世界のペプチドマイクロアレイ市場規模・現状・予測（2021年-2027年）

Global Peptide Microarray Market Size, Status and Forecast 2021-2027
QFJ1-4679 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ペプチドマイクロアレイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質機能解析、プロテオミクス）、用途別市場規模（病院、クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のB型ナトリウム利尿ペプチド検査市場規模・現状・予測（2021年-2027年）

Global B-type Natriuretic Peptide Test Market Size, Status and Forecast 2021-2027
QFJ1-3946 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、B型ナトリウム利尿ペプチド検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（精密機器、消耗品、その他）、用途別市場規模（病院・診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のN末端プロB型ナトリウム利尿ペプチド市場規模・現状・予測（2021年-2027年）

Global N-terminal Pro B-type Natriuretic Peptide Market Size, Status and Forecast 2021-2027
QFJ1-4597 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、N末端プロB型ナトリウム利尿ペプチドの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（器具、消耗品、その他）、用途別市場規模（病院・クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、...

世界の脳性ナトリウム利尿ペプチド（BNP）検査市場規模・現状・予測（2021年-2027年）

Global Brain Natriuretic Peptide (BNP) Test Market Size, Status and Forecast 2021-2027
QFJ1-3934 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脳性ナトリウム利尿ペプチド（BNP）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（器具、消耗品、その他）、用途別市場規模（病院＆診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、...

世界のGLP-1Rアゴニスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global GLP-1R Agonist Market The global GLP-1R Agonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
グルカゴン様ペプチド2受容体のグローバル市場調査 2019年 The global Glucagon Like Peptide 2 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glucagon Like Peptide 2 Receptor volume and value at global level, regional level and company level. From …
グルカゴン様ペプチド-1（GLP-1）刺激薬のグローバル市場2021 Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Un…
世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global GLP-1 Receptor Agonists Market The global GLP-1 Receptor Agonists market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global N-Formyl Peptide Receptor 2 Market The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…